Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Ameren
AEE
$31.1B
| $21.9M | 0.01% |
311,866
-166,908
| -35% | -$12.1M |
|
677
Ingles Markets
IMKTA
$1.71B
| $21.7M | 0.01% |
503,116
-149,918
| -23% | -$6.08M |
|
|
678
Shopify
SHOP
$169B
| $21.6M | 0.01% |
227,870
-2,537,060
| -92% | -$176M |
|
679
Criteo
CRTO
$1.06B
| $21.5M | 0.01% |
1,893,573
+967,744
| +105% | +$10.2M |
|
680
Packaging Corp of America
PKG
$22.6B
| $21.5M | 0.01% |
215,331
+85,228
| +66% | +$8.11M |
|
681
Martin Marietta Materials
MLM
$35B
| $21.3M | 0.01% |
103,056
-191,822
| -65% | -$36.9M |
|
682
Equifax
EFX
$22B
| $21.3M | 0.01% |
123,701
-244,968
| -66% | -$36.3M |
|
683
Phibro Animal Health
PAHC
$1.48B
| $21.2M | 0.01% |
808,202
+128,008
| +19% | +$3.18M |
|
684
Stoneridge
SRI
$208M
| $21.2M | 0.01% |
1,026,121
+270,187
| +36% | +$5.06M |
|
685
Applied Materials
AMAT
$378B
| $21.2M | 0.01% |
350,246
-953,159
| -73% | -$51.4M |
|
686
Leggett & Platt
LEG
$1.47B
| $21.2M | 0.01% |
601,899
+432,353
| +255% | +$13.4M |
|
687
American Vanguard Corp
AVD
$74.1M
| $21M | 0.01% |
1,523,730
+282,247
| +23% | +$3.79M |
|
688
Thomson Reuters
TRI
$45.1B
| $20.9M | 0.01% |
293,354
-250,417
| -46% | -$18.1M |
|
|
ANSS
689
DELISTED
Ansys
ANSS
| $20.9M | 0.01% |
71,716
-186,574
| -72% | -$49.7M |
|
690
Church & Dwight Co
CHD
$23.7B
| $20.9M | 0.01% |
270,556
+127,482
| +89% | +$9.27M |
|
691
Enterprise Products Partners
EPD
$83.6B
| $20.7M | 0.01% |
1,139,226
-47,400
| -4% | -$848K |
|
692
Telus
TU
$16.7B
| $20.6M | 0.01% |
1,233,231
-3,041,671
| -71% | -$50.6M |
|
693
Brown & Brown
BRO
$24.6B
| $20.5M | 0.01% |
502,699
-497,483
| -50% | -$19.2M |
|
694
HCA Healthcare
HCA
$92.8B
| $20.4M | 0.01% |
210,616
-589,657
| -74% | -$61.3M |
|
695
Cheniere Energy
LNG
$52.8B
| $20.1M | 0.01% |
416,262
-43,847
| -10% | -$1.92M |
|
|
DCPH
696
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $20M | 0.01% |
335,002
-1,334
| -0.4% | -$71.4K |
|
697
Fortinet
FTNT
$110B
| $20M | 0.01% |
727,880
-351,325
| -33% | -$8.82M |
|
698
Incyte
INCY
$26B
| $19.9M | 0.01% |
191,277
+111,650
| +140% | +$10.8M |
|
|
IPG
699
DELISTED
Interpublic Group of Companies
IPG
| $19.6M | 0.01% |
1,142,003
+913,466
| +400% | +$15.1M |
|
700
ScottsMiracle-Gro
SMG
$4.25B
| $19.5M | 0.01% |
145,278
+9,992
| +7% | +$1.29M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.